Earnings call transcript: Indexo achieves first consolidated profit in Q1 2024

Indexo Group reported its first consolidated profit after the Delfin Group acquisition, with Q1 consolidated revenue of €12.7 million and group-level profitability supported by €0.5 million from pensions and €1.9 million from Delfin profits. The loan book rose 11% quarter over quarter to €248 million, capital adequacy remained strong at about 25%, and the bank said it is on track to reach monthly breakeven by year-end. Shares rose 1.62% to €8.66 as investors reacted positively to the improving earnings and growth trajectory.

Analysis

The market is underestimating how quickly this setup can turn into a financing flywheel. Once one part of the ecosystem generates cash, the group can subsidize growth in the banking arm, which compresses funding costs, accelerates product rollouts, and makes deposit gathering a competitive weapon rather than just a balance-sheet necessity. That matters because the economics here are increasingly path-dependent: cheaper retail funding lowers loan spreads, which supports faster loan growth, which in turn improves scale economics and widens the gap versus smaller lenders reliant on wholesale markets.

The bigger second-order effect is not the headline profitability, but the signal that capital intensity is now manageable enough to keep expanding without immediate dilution. That reduces the probability of an equity overhang in the next 6-12 months and should support a rerating if execution stays intact. The main risk is that the credit book is still young; early-stage asset quality can look pristine precisely when provision charges are front-loaded, so the real test comes over the next 2-4 quarters as vintages season and macro normalization stops helping.

Consensus is probably too focused on the first consolidated profit and not enough on the quality of the funding mix. If deposit growth keeps outpacing loan growth, the earnings slope can improve faster than investors expect; if not, margin expansion stalls and the story reverts to a capital-hungry growth platform. The most important watch item is whether management can keep execution cadence high enough to hit breakeven without sacrificing underwriting discipline, because that is where the multiple expansion case either compounds or breaks.

For NVDA specifically, the CEO-China visit is a modest sentiment tailwind, not a fundamental inflection. The real read-through is that policy optics are improving around advanced semis, which can help near-term multiple support, but any benefit is likely transient unless export restrictions ease materially.

Key Decisions for Investors

• Long IDX1R/INDEXO on a 3-6 month horizon into the breakeven catalyst: favor entry on any pullback, with upside tied to deposit growth and operating leverage; cut if loan growth accelerates without deposit mix improvement.
• Pair trade: long IDX1R vs short a regional wholesale-funded lender or non-bank consumer lender over 6 months, to express the view that cheaper funding wins in a rising-rate/competitive deposit environment.
• Use call spreads on IDX1R rather than outright equity if liquidity allows: 6-12 month upside is driven by a rerating on execution, but downside remains meaningful if provisions or funding costs reaccelerate.
• For NVDA, consider a short-dated call spread only if you want to trade the event-driven China-visit optimism; keep size small because the catalyst is more headline than earnings-revising.
• Watch for a second entry point in 2Q results: if net deposits continue to outrun loans and Stage 2/3 stays contained, add to long exposure; if not, fade the move.